Skip to content
Rutgers.edu
New Brunswick
RBHS
Newark
Camden
Online
Rutgers Health

Facebook
X

Search for: Hit enter to search or ESC to close

Institute for Translational Medicine and Science

Home
About
Investigator Resources
Clinical Trials Resources
Education & Training
Faculty
News
Contact Us

Select Page

Home / News / NJIT’s Xu is Developing a Timed-Release mRNA Vaccine with an Extended Shelf Life / xiaoyang-Xu2

xiaoyang-Xu2

by | Oct 6, 2021

xiaoyang-Xu2

Recent Posts

Revealing the Heavy Impacts of Repeated Low-Level Head Traumas.
New NJACTS Publication
Applications for TIN Training Program for Multicenter Clinical Trial Management: Due MAY 30, 2025
Frequent Exposure to Gun Violence Is Associated with Depression, Suicide and Mental Health.
Two-Thirds of U.S. Adolescent Minors Are Impacted by State Abortion Restrictions.

Archives

2025
2024
2023
2022
2021
2020
2019
2018
- July
- April
2017
- October
- April
2016
2015
- July
- February
2013
- November

Categories

News (2,524)
Publication (1)

THIS SITE

Investigator Resources

Clinical Trials Resources

Education & Training

CONTACT US

Rutgers Institute for Translational Medicine and Science
Rutgers, The State University of New Jersey
Child Health Institute of New Jersey Building
89 French Street, Suite 4210
New Brunswick, NJ 08901

Facebook
Twitter

© 2019-2020, Rutgers Institute for Translational Medicine and Science. All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.